Features of the Legal Regulation of Biobank Bankruptcy in the Russian Federation
https://doi.org/10.17803/lexgen-2025-4-4-93-109
Abstract
The rapid development of biomedical technologies and the growing number of biobanks in the Russian Federation underscores the importance of their legal regulation, particularly in relation to potential insolvency (bankruptcy). This study aims to identify the specific features of legal regulation of biobank bankruptcy, taking into account the unique nature of their assets and their social significance. The research was conducted using an integrated approach, including an analysis of bankruptcy legislation and civil law governing the circulation of biological materials, judicial practice, and doctrinal sources. The research methodology involved the principles of analysis and synthesis, comparative and formal legal analysis, as well as the method of systems analysis. The conducted research has revealed gaps and ambiguities in the current legal regulation of biobank bankruptcy, particularly concerning the legal status of biological materials, procedures for their valuation and inclusion in the bankruptcy estate, and the protection of donors’ and patients’ rights. Risks associated with the potential misuse or improper disposal of biological materials during bankruptcy proceedings are identified. In conclusion, recommendations for improving bankruptcy legislation to reflect the specific characteristics of biobank activities are provided. These recommendations aim to ensure the safety of biological materials, safeguard the rights of donors and patients, and enhance the transparency and predictability of biobank bankruptcy procedures. The study emphasizes the need to develop special rules for regulating the bankruptcy of biobanks, taking into account their operational particularities and the unique nature of their assets
Keywords
About the Author
O. A. Enikeev
Bashkir Academy of Public Administration under the Head of the Republic of Bashkortostan
Russian Federation
Russian Federation
Oleg A. Enikeev, Candidate of Science (Law), Candidate of Science (Medicine), Associate Professor of the Department of Civil Law and Procedure
Ufa
References
1. Balashova, A.I. (2023). Features of the legal regime of databases classified as biobanks. Intellectual Property. Copyright and Related Rights, (3), 18–33. (In Russ.).
2. Bobyleva, A.Z. (2010). The modernisation of bankruptcy institute as the key factor of increasing the efficiency of market economy. Lomonosov Public Administration Journal. Series 21, (3), 39–60. (In Russ.).
3. Boltanova, E.S., Imekova, M.P. (2021). Types of biological databases (biobanks). Bulletin of Tomsk State University. Journal of Law, (41), 136–148. (In Russ.). https://doi.org/10.17223/22253513/41/12
4. Dosmagulova, D.M. (2020). Legal fate of biological materials upon termination of biobanks: the experience of the Republic of Kazakhstan, the Commonwealth of Independent States and the European Union. Medical Law: Theory and Practice, 6(2), 104–108. (In Russ.).
5. Ducato, R., Perra, S., Zuddas, C. (2014). The legal fate of biobanks between privacy, IPRs and crisis of a firm. A preliminary study on the case of "bio-bankruptcy". Law and the Human Genome Review, (41), 89–102.
6. Gavrilenko, S.M. (2017). Biobanking and contemporary regime of biopolitics: the territory of social and ethical tension. In: Revolution and Evolution: Models of Development in Science, Culture, and Society. Collection of scientific articles. (pp. 143–147). Nizhny Novgorod: National Research Lobachevsky State University of Nizhny Novgorod. (In Russ.).
7. Grin O.S., Grin E.S. (2020). Rights Accounting Systems for Various Contractual Relations. Actual Problems of Russian Law, 15(10), 95–104. (In Russ.) https://doi.org/10.17803/1994-1471.2020.119.10.095-104
8. Ivshina, I.B., Kuyukina, M.S. (2018). Specialized Microbial Resource Centers: A Driving Force of the Growing Bioeconomy. In: Sharma, S., Varma, A. (eds.) Microbial Resource Conservation. Soil Biology, 54, 111–139. Springer, Cham. https://doi.org/10.1007/978-3-319-96971-8_4
9. Janger, E.J. (2005). Genetic information, privacy and insolvency. Journal of Law, Medicine & Ethics, 33(1), 79–88. https://doi.org/10.1111/j.1748-720x.2005.tb00212.x
10. Kaiser, J. (2009). Cash-starved deCODE is looking for a rescuer for its biobank. Science, 325(5944), 1054. https://doi.org/10.1126/science.325_1054
11. Kalinichenko, P.A., Ponomareva, D.V. (2019). Ethical and legal aspects of regulating genomic research in international and Russian practice. Medical Radiology and Radiation Safety, 64(5), 69–70. (In Russ.). https://doi.org/10.12737/1024-6177-2019-64-5-69-70
12. Kartashkov, D.V. (2021). Components of the Human Body as Objects of Civil Law. Pravovedenie, 65(4), 404–420. (In Russ.). https://doi.org/10.21638/spbu25.2021.403
13. Koval, A.V. (2024). Issues of protection of public interests in the law enforcement practice of bank-ruptcy of strategic enterprises. State and Law, (4), 77–85. (In Russ.). https://doi.org/10.31857/S1026945224040054
14. Kravchenko, D.A., Bogdanova, T.D. (2023). Biomaterials: concept and place in the system of civil rights objects. Nauchnyi aspekt, 8(5), 890–896. (In Russ.).
15. Magalon, J., Maiers, M., Kurtzberg, J., Navarrete, C., Rubinstein, P., Brown, C., ... Katz, G. (2015). Banking or bankrupting: strategies for sustaining the economic future of public cord blood banks. PLoS One, 10(12), e0143440. https://doi.org/10.1371/journal.pone.0143440
16. Mokhov, A.A., Ershova, I.V., Andreeva, L.V., Andronova, T.A., Shevchenko, O.A., Shilyuk, T.O., … Shniger D.O. (2015). Medical Law of Russia. Moscow: Infra-M Publ. (In Russ).
17. Nozdracheva, A.V., Carbone, G., Rybak, L.A., Semenenko, T.A., Cherkasov, V.V., Skitova, V.M. (2024). Population biobank: concept and modern information and technical support for epidemiological studies. Belgorod: Belgorod State Technological University named after V.G. Shukhov. (In Russ.).
18. Osmanova, D.S. (2024). Competitivity Issues Related to Biobank Activity. Lex Genetica, 3(1):7–32. (In Russ.) https://doi.org/10.17803/lexgen-2024-3-1-7-32
19. Piciocchi, C., Ducato, R., Martinelli, L., Perra, S., Tomasi, M., Zuddas, C., Mascalzoni, D. (2018). Legal issues in governing genetic biobanks: the Italian framework as a case study for the implications for citizen’s health through public-private initiatives. Journal of Community Genetics, 9, 177–190. https://doi.org/10.1007/s12687-017-0328-2
20. Romanovsky, G.B. (2024). Transformation of human legal personality in the context of the development of biomedical technologies. In: Human. Culture. Society. Proceedings of the XIV International Scientific and Practical Conference, Penza, April 18-19, 2024 (pp. 219–224). Penza: Penza State University. (In Russ.).
21. Shandro, M.I. (2025). Legal Issues of Including Biomaterials in the Debtor’s Bankruptcy Estate. In: Proceedings of the XXVI International Scientific and Practical Conference of Kutafin Moscow State Law University (MSAL) and the XXV International Scientific and Practical Conference of the Law Faculty of Lomonosov Moscow State University, within the framework of the XIV Moscow Legal Week, Moscow, November 26–29, 2024 (pp. 87–91). Moscow: Kutafin Moscow State Law University (MSAL). (In Russ.).
22. Shinkaretskaya, G.G., Rednikova, T.V. (2021). Legal regulation of the creation and operation of biobanks as a tool for the development of genetic research: international experience. Union of Criminalists and Criminologists, (4), 74–78. (In Russ.).
23. Shlyakhto, E.V., Konradi, A.O. (2021). Personalized Medicine. History, current state and future directions. Russian Journal for Personalized Medicine, 1(1), 6–20. (In Russ.).
24. Slabospitsky, A.S., Solovieva, D.A. (2023). Executive immunity in bankruptcy of the debtor. Journal of Legal Sciences, (3), 31–38. (In Russ.).
25. Sushkova, O.V. (2020). Legal Issues of Management of Genetic Biobanks in Italy with Insufficiency and Bank-ruptcy: State-Private Initiatives and Patenting. The Rule of Law, (2), 99–116. (In Russ.).
26. Terui-Kohbata, H., Ueda, H., Yoshida, M. (2025). Re-consent practices in biobanks in Japan: current status and stakeholder perspectives. Journal of Community Genetics, 16, 639–645. https://doi.org/10.1007/s12687-025-00820-4
27. Tutton, R. (2011). Promising pessimism: Reading the futures to be avoided in biotech. Social Studies of Science, 41(3), 411–429. http://www.jstor.org/stable/41301939
28. Tuzhilova-Ordanskaya, E.M., Akhtyamova E.V. (2021). Issues of civil law regulation regarding the protection of civil rights when using genetic information in the Russian Federation. Perm University Herald. Juridical Sciences, (52), 263–284. (In Russ.). https://doi.org/10.17072/1995-4190-2021-52-263-284
29. Tyumina, O.V., Volchkov, S.E., Ovchinnikov, P.A., Bugakov, A.I., Porapov, I.V., Prihodko A.V., Prihodko, E.M., Komarova O.V. (2023). Analysis of the activities of cord blood banks in the Russian Federation. Genes & Cells, 18(3), 205–218. (In Russ.). https://doi.org/10.23868/gc486812
30. Vasiliev, G.S. (2018). Human biomaterial as an object of law. Pravovedenie, (2), 308–361. (In Russ.). https://doi.org/10.21638/11701/spbu25.2018.205
31. Zawati, M.N.H., Borry, P., Howard, H.C. (2011). Closure of population biobanks and direct-to-consumer genetic testing companies. Human Genetics, 130, 425–432. https://doi.org/10.1007/s00439-011-1019-4
32. Zhukova, T.M., Kondratieva K.S. (2014). Modern Features of the Application of Economic Models for Diagnosing the Probability of Bankruptcy of Legal Entities. Perm University Herald. Juridical Sciences, (1), 197–205. (In Russ.).
Review
For citations:
Enikeev O.A. Features of the Legal Regulation of Biobank Bankruptcy in the Russian Federation. Lex Genetica. 2025;4(4):93-109. (In Russ.) https://doi.org/10.17803/lexgen-2025-4-4-93-109
Views:
304
JATS XML
Email this article 